Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.00 | 10.38 |
| PEG Ratio (TTM) | N/A | 1.19 |
| P/S Ratio (TTM) | 0.00 | 4.73 |
| P/B Ratio (TTM) | 0.00 | 3.28 |
| P/FCF Ratio (TTM) | 0.00 | 22.43 |
| Price to 5YR AVG Earnings Ratio | 0.00 | 30.40 |
| Price to 5YR AVG FCF Ratio | 0.00 | 19.06 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -32.72% | 3.16% |
| ROE (TTM) | -37.93% | 9.61% |
| Net Profit Margin (TTM) | -120.87% | -15.77% |
| ROIC 5YR AVG | -59.26% | 7.94% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 18.43% | 22.08% | 29.44% |
| Revenue | 2.38% | 27.18% | 19.04% |
| Net Income | 13.96% | -250.03% | -144.40% |
| Cash Flow | 13.11% | -263.59% | -142.12% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.40 | 2.56 |
| Quick Ratio (TTM) | 1.63 | 1.93 |
| D/E Ratio (TTM) | 0.05 | -0.48 |
| Interest Coverage (TTM) | -296.04 | 16.24 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | N/A | 4.96 |
| LTL to 5YR AVG FCF | -0.04 | 4.89 |
| Shares Outstanding Growth 5YR AVG | 58.72% | 28.20% |